Loading...
Metabolic Capacity Expansion And Peptide Outsourcing Shifts Will Face Headwinds Yet Ultimately Support Upside
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
12.0%7D
-8.1%1Y
12.0%7D
-8.1%You can edit this narrative until Dec 17 1:05 PM. Then, changes will post as Updates.